Surmodics, Inc. SRDX recently announced the successful early clinical use of the company’s Pounce LP (Low Profile) Thrombectomy System. With the addition of a low-profile device, the Surmodics Pounce ...

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced successful early clinical use of the ...

Pulmonary embolism (PE) remains a major cause of cardiovascular morbidity and mortality worldwide. It occurs when thrombotic material—most often ...

With the addition of the Pounce™ XL Thrombectomy System, indicated for use in 5.5–10 mm peripheral arteries, the fully mechanical Pounce™ Thrombectomy Platform can now remove thrombi or emboli ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Analysis of the all-comers PROWL Registry demonstrated high procedural success and safety in a cohort reflecting the real-world complexity of patients with symptomatic limb ischemia, over 40% of whom ...

The Pounce™ Thrombectomy Platform can now be used to remove clot from peripheral arteries as small as 2mm up to as large as 10 mm in diameter, broadening the platform's clinical utility and ...

PLEASANTON, Calif., Sept. 11, 2024 /PRNewswire/ -- FlowPhysix(TM) Inc, formerly known as Expanse ICE, is pleased to announce a strategic partnership with 3comma Medical / 3comma Medical GmbH who will ...

As an interventional radiologist at Palmetto General Hospital, I have over 15 years of experience treating venous thromboembolic disease and have comp ...

Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform Analysis of 160 patients with ...

Boston will inherit products, including Penumbra’s Lightning thrombectomy systems, to advance its vascular care provision.

Abbott Laboratories, has acquired Walk Vascular LLC, a deal that brings two devices for peripheral thrombectomy to the Abbott portfolio for peripheral artery disease (PAD). Walk’s two Jeti peripheral ...